title: Effect of serum subfractions from peritoneal dialysis patients on Hep-G2 cell apolipoprotein A-I and B metabolism.
abstract: We previously showed that uremic serum subfractions isolated from hemodialysis (HD) patients inhibited the production of apolipoprotein (apo) A-I by human hepatoblastoma cells, Hep-G2. Because of the reported differences in atherogenic cardiovascular mortality between HD and peritoneal dialysis (PD) patients, we examined the effect of similar subfractions from PD patients on apo A-I and apo B synthesis. After obtaining informed consent, serum samples from five normal subjects and nine stable PD patients were applied to Sephadex G-25 columns to obtain the serum subfractions used in the various experiments. Sephadex G-25 chromatograms of PD sera showed a broad peak from fractions 30 through 60 (molecular wt 500 to 2000 Da). Control serum showed no peak in this region. PD serum subfractions decreased apo A-I synthesis, secretion, and apo A-I mRNA expression by Hep-G2 cells when compared to subfractions from control subjects. Cholesterol efflux studies showed that conditioned media obtained from Hep-G2 cells incubated with PD serum subfractions inhibited cholesterol efflux from fibroblasts, suggesting a biologically-significant decrease in apo A-I synthesis. PD serum subfractions increased protein synthesis and mRNA expressions of apo B by Hep-G2 cells. Therefore, serum subfractions obtained from PD patients decreased apo A-I and increased apo B synthesis, findings consistent with their serum lipoprotein profiles suggesting that a biologically-active component in these subfractions could contribute to the risk of atherogenic cardiovascular disease in PD.
authors.affiliation: Section of Nephrology, Department of Veterans Affairs Medical Center, Long Beach, California, USA.
authors.forename: G M
authors.initials: GM
authors.lastname: Shah
authors.forename: Z L
authors.initials: ZL
authors.lastname: Lin
authors.forename: V S
authors.initials: VS
authors.lastname: Kamanna
authors.forename: R
authors.initials: R
authors.lastname: Pai
authors.forename: B
authors.initials: B
authors.lastname: Bassa
authors.forename: F Y
authors.initials: FY
authors.lastname: Jin
authors.forename: D D
authors.initials: DD
authors.lastname: Roh
authors.forename: M L
authors.initials: ML
authors.lastname: Kashyap
authors.forename: M A
authors.initials: MA
authors.lastname: Kirschenbaum
mesh_terms: D016632:Apolipoprotein A-I / Q000378:metabolism*; D001055:Apolipoproteins B / Q000235:genetics / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism; D018197:Hepatoblastoma / Q000378:metabolism; D006801:Humans; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory; D012333:RNA, Messenger / Q000032:analysis; D014407:Tumor Cells, Cultured; D014511:Uremia / Q000097:blood*
chemical_list: D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D012333:RNA, Messenger; D002784:Cholesterol